PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer.

Kwee SA, Wong L, Chan OTM, Kalathil S, Tsai N. PET/CT with 18F Fluorocholine as an Imaging Biomarker for Chronic Liver Disease: A Preliminary Radiopathologic Correspondence Study in Patients with Liver Cancer. Radiology. 2018 04; 287(1):294-302.

View in: PubMed

subject areas

Aged
Choline
Chronic Disease
Female
Fluorine Radioisotopes
Humans
Liver
Liver Neoplasms
Male
Middle Aged
Prospective Studies
Radiopharmaceuticals
Reproducibility of Results
Sensitivity and Specificity

authors with profiles

Sandi Kwee, MD, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support